Book Value per Share: Cassava Sciences, Inc. (SAVA)

Cassava Sciences, Inc. (SAVA) - corporate logo

Cassava Sciences, Inc. (SAVA) is developing a breakthrough protein correction method for Alzheimer's, leveraging patent protection for its molecules despite regulatory challenges. The bps trend reflects the actual net asset base, where the value 1.70 represents the current metric. Final approval of Simufilam will grant the company absolute pricing power due to the highly inelastic demand for the therapy.

Cassava Sciences Inc (SAVA) Equity per Share: for the period 07/04/2022 - 03/11/2026

cassavasciences.com - analytical breakdowns and key metrics (SAVA)

- price and consensus price forecast:
Stock Quotes Cassava|SAVA - Price Target Chart
- market capitalization data:
Market Capitalization Cassava Sciences, Inc.|SAVA - Enterprise Value
- book capitalization data:
Net Assets per Single Share Cassava Sciences|SAVA - Accounting Capitalization|Market Capitalization to Book Value Ratio cassavasciences.com|SAVA - Company Assets
- debt and liquidity data:
Total Debt to Equity Ratio Cassava Sciences, Inc.|SAVA - Long-Term Debt to Capital|Short-Term Debt to Equity Cassava Sciences|SAVA - Aggregate Debt Obligations|Debt to Book Capitalization Ratio Cassava Sciences, Inc.|SAVA - Long-Term Debt|Company Short-Term Debts Cassava Sciences
Fundamental company valuation:Cassava, SAVA
Manufactured products of Cassava Sciences

Book value per share determines the portion of equity attributable to a single security after deducting all liabilities from total assets. By analyzing the capital level per share, an investor assesses the financial resilience of Cassava Sciences, Inc. (SAVA) regarding costly clinical trials for Alzheimer's drugs, where maintaining a significant reserve is critical for overcoming regulatory barriers and minimizing the risks of failure.

Competitors of Cassava Sciences, Inc. (SAVA)

BIIB - Accounting Value per Share|NBIX - Net Assets per Single Share|RGC: Book Value per Share|AXSM (axsome.com) - Book Value per Share|Net Assets per Single Share ACADIA Pharmaceuticals Inc. (ACAD)|Equity per Share Xenon Pharmaceuticals Inc.|Viking Pharma - Book Value per Share|Net Asset Value per Share Supernus Corp SUPN|Accounting Value per Share CPRX (Catalyst Pharmaceuticals)|denalitherapeutics.com - Book Value per Share|Net Assets per Single Share Harmony Biosciences Holdings, Inc. (HRMY)|BHVN: Accounting Value of a Share|Net Assets per Single Share AMLX|Trevi Corp (TRVI) - Net Asset Value per Share|Book Value per Share PRAX|Accounting Value per Share anavex.com|Book Value per Share CBLL|Book Value per Share PRTA (Prothena Corporation)|Net Assets per Single Share ALEC|Annexon Biosciences Inc. - Net Assets per Share|Net Assets per Single Share OMER (Omeros Corp.)|NGNE - Net Assets per Share|ACIU: Book Value per Share|Book Value per Share Voyager Therapeutics Inc|Accounting Value per Share Neumora Therapeutics Inc|Net Assets per Single Share Scilex Holding Company, Inc.|Book Value per Share TVGN|Book Value per Share alphacognition.com ACOG|Accounting Value per Share Cognition Therapeutics|Inhibikase Therapeutics Inc - Accounting Value of a Share|Net Assets per Single Share ASRT (Assertio Therapeutics)|COYA - Net Assets per Share|VTGN (vistagen.com) - Book Value per Share|Ovid Therapeutics (OVID) - Accounting Value per Share|ABOS: Book Value per Share|Net Assets per Share CervoMed, Inc.|Alterity Therapeutics - Book Value per Share|Net Asset Value per Share CLNN (clene.com)|PEPG - Net Assets per Single Share|Equity per Share Jupiter Neurosciences, Inc. JUNS|RLMD: Book Value per Share|ANVS - Accounting Value per Share|Book Value per Share GRCE|AIFF (Firefly Neuro) - Net Asset Value per Share|KLTO: Net Assets per Single Share|Net Assets per Share NeuroSense Therapeutics, Ltd. (NRSN)|Reviva Pharmaceuticals Holdings, Inc. (RVPH) - Accounting Value per Share|Accounting Value of a Share metaviatx.com (MTVA)|Book Value per Share NRXS|Helius Medical Technologies, Inc. - Net Assets per Share|Passage Bio Corp (PASG) - Net Assets per Single Share|NEUP - Equity per Share|NERV (Minerva Neurosciences, Inc.) - Book Value per Share|Accounting Value per Share Athira Pharma Inc|ADXN: Accounting Value per Share|Net Assets per Share ALZN|CYCN (Cyclerion Therapeutics) - Net Assets per Single Share|Net Assets per Share protagenic.com (PTIX)|Book Value per Share KTTA (Pasithea Therapeutics Corp.)|CRGT - Book Value per Share|ATXI - Accounting Value per Share|BCLI - Net Assets per Single Share|CARA: Book Value per Share|CHRO (chromocell.com) - Book Value per Share|Net Assets per Single Share Eliem Therapeutics, Inc. (ELYM)|Equity per Share Intra-Cellular|Longboard Pharma - Book Value per Share|Net Asset Value per Share Marinus Pharma MRNS|Accounting Value per Share NKGN (NKGen Biotech, Inc.)|neurobopharma.com - Book Value per Share|Net Assets per Single Share Sage Therapeutics (SAGE)|SNPX: Accounting Value of a Share|Net Assets per Single Share TRVN|Vigil Neuroscience, Inc. (VIGL) - Net Asset Value per Share|Book Value per Share WENA|Accounting Value per Share cerevel.com